← Eichor
Study identifier: NCT06183645 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

Condition: Chronic Inflammatory Demyelinating Polyneuropathy  ·  Sponsor: Centre Hospitalier Universitaire de Liege

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.

This description comes directly from the study's public registry record.

Talk to the study team

Laurie Medard  ·  043215584  ·  laurie.medard@citadelle.be

Margaux Poleur, Dr  ·  04216127  ·  margaux.poleur@citadelle.be

Always discuss trial participation with your own doctor first.

Locations (1)

CHR CitadelleLiège, Liège, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06183645